Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)

v3.7.0.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Jun. 30, 2017
Jun. 30, 2016
Operating Expenses        
Research and development $ 190,648 $ 381,119 $ 2,461,722 $ 1,009,975
General and administrative 1,797,749 1,464,551 4,313,703 2,515,069
Stock-based compensation - general and administrative 266,812 280,764 808,356 515,677
Total Operating Expenses 2,255,209 2,126,434 7,583,781 4,042,721
Operating Loss (2,255,209) (2,126,434) (7,583,781) (4,042,721)
Other Income (Expense), Net:        
Interest income 782 800
Gain (loss) on revaluation of derivative warrant liability (133,512) (1,485,832) 308,878 (1,659,738)
Interest expense (33,700) (4,445) (66,779) (4,445)
Total Other Income (Expense), Net (167,212) (1,489,495) 242,099 (1,663,383)
Loss before Income Taxes (2,422,421) (3,615,929) (7,341,682) (5,706,104)
Net Loss $ (2,422,421) $ (3,615,929) $ (7,341,682) $ (5,706,104)
Net Loss Per Share - Basic and Diluted $ (0.49) $ (0.75) $ (1.45) $ (1.78)
Weighted Average Common Shares Outstanding Basic and diluted 4,952,558 4,844,235 5,047,593 3,203,822